Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
Amwell is recognized by Frost & Sullivan for its unified technology-enabled care platform designed to reduce healthcare fragmentation and support digital care at scale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amwell (AMWL) received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms industry. The award highlights Amwell's unified platform that connects consumer experiences, clinician workflows, care programs, and partner solutions to reduce healthcare fragmentation.
Frost & Sullivan's 12‑month evaluation assessed Amwell across technology leverage factors such as innovation, development efficiency, and commercialization, and business impact factors including financial performance, customer acquisition, and growth potential. The Amwell Platform is described as reliable, flexible, and clinically integrated, supporting large-scale virtual care, condition management, remote monitoring, and digital therapeutics for health plans and healthcare organizations.
Details
News Market Reaction – AMWL
On Sep 3, the day this news came out, AMWL closed 2.96% above the previous close. Our momentum scanner recorded 8 alerts for this stock that day. Relative volume reached 1.9x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Recognition year
- 2026
- Frost & Sullivan technology innovation leadership recognition
- Analytical process
- 12 months
- Frost & Sullivan evaluation
- Evaluation dimensions
- two dimensions
- Technology leverage and business impact
Historical Context
-
Restricted stock units granted to two new non-executive employees
-
Revenue reached guidance high end and full-year outlook improved
-
Company scheduled its second-quarter operating results announcement
-
Randomized study reported lower mental-disorder prevalence with SilverCloud
-
Company announced participation in the Needham technology conference
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
digital therapeutics medical
remote monitoring medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell's ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions.
“Our vision is that healthcare works better when technology brings the ecosystem together,” said Dan Zamansky, Chief Product and Technology Officer at Amwell. “We're building the integrated infrastructure that connects patients, providers, health plans, and virtual care solutions, and this award reflects our commitment to that mission.”
The recognition followed a 12-month analytical process that evaluated Amwell across two dimensions: technology leverage — including innovation, creativity, development efficiency, commercialization, and application diversity; and business impact — including financial performance, customer acquisition, operational efficiency, growth potential, and human capital. The evaluation shows that Amwell's platform approach delivers measurable results for customers.
Sagar Mukhekar, Industry Analyst at Frost & Sullivan said, “The combination of reliability, flexibility, and clinically integrated workflows positions the Amwell Platform as a strategic enabler for organizations seeking to reduce fragmentation, improve member engagement with covered programs, expand access to care, and create more connected healthcare experiences.”
Healthcare organizations have expanded their digital capabilities over time, but this growth often creates new problems. Virtual care, condition management, remote monitoring, and digital therapeutics can operate as disconnected point solutions, resulting in fragmented patient experiences, duplicate processes, and significant administrative burden. Amwell offers a different approach by providing a connected foundation that unifies consumer interactions, clinician workflows, care programs, and partner ecosystems within a common architecture.
About Amwell
Amwell offers health plans and healthcare organizations a single, comprehensive, technology-enabled care platform. We use technology to provide consumers with better access to more convenient, affordable, and effective care. The Amwell Platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows consumers to experience unified, personalized, and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell Platform is proven, operating at a large scale, enabling care for millions while delivering dependable outcomes. For two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Forward-Looking Statements
This article contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements about the future of digital health, the role of artificial intelligence, data, and automation in care delivery, and Amwell’s strategy and priorities. These statements reflect current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including those described under “Risk Factors” in Amwell’s most recent Annual Report on Form 10-K and in subsequent Quarterly Reports on Form 10-Q, available at investors.amwell.com. Amwell undertakes no obligation to update any forward-looking statement.
Investors:
Asher Dewhurst
amwell@icrhealthcare.com
Media:
press@amwell.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What award did Amwell (AMWL) receive from Frost & Sullivan in 2026?
Amwell (AMWL) received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms industry. The recognition focuses on its technology-enabled care platform and its role in addressing healthcare fragmentation.
Why did Frost & Sullivan recognize Amwell (AMWL) with a Technology Innovation Leadership award?
Frost & Sullivan recognized Amwell for its unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions. The firm highlighted the platform's reliability, flexibility, and clinically integrated workflows as enablers of more connected, less fragmented healthcare.
How did Frost & Sullivan evaluate Amwell (AMWL) for the 2026 Technology Innovation Leadership Recognition?
The recognition followed a 12‑month analytical process evaluating Amwell in two areas: technology leverage (innovation, creativity, development efficiency, commercialization, application diversity) and business impact (financial performance, customer acquisition, operational efficiency, growth potential, and human capital).
How does the Amwell Platform help reduce healthcare fragmentation for AMWL customers?
The Amwell Platform offers a connected foundation that unifies consumer interactions, clinician workflows, care programs, and partner ecosystems within a common architecture. This approach is intended to replace disconnected point solutions that can cause fragmented experiences and duplicate processes.
What types of digital health programs does the Amwell (AMWL) platform support?
The Amwell Platform supports virtual care, condition management, remote monitoring, and digital therapeutics, along with many clinical programs from Amwell and its partners. It is described as operating at large scale, enabling care for millions while delivering dependable outcomes.